SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)

3 Months Ended

Mar. 31, 2024

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

Schedule of consolidated financial statements reflect the activities

Name	Background	Ownership
Yubo International Biotech Limited (“Yubo New York”)	·          A holding company  ·          Incorporated in New York
Platinum International Biotech Co. LTD (“Platinum”)	·   A Cayman Island company ·      Incorporated on April 7, 2020 ·      A holding company	100% owned by Yubo New York
Platinum International Biotech (Hong Kong) Limited. (“Platinum HK”)	·      A Hong Kong company ·      Incorporated on May 4, 2020 ·      A holding company	100% owned by Platinum
Yubo International Biotech (Chengdu) Limited (“Yubo Chengdu”)	·      A PRC company and deemed a w holly foreign owned enterprise ·      Incorporated on September 4, 2020 ·      Subscribed capital of $1,500,000 ·      A holding company	100% owned by Platinum HK
Yubo International Biotech (Beijing) Limited (“Yubo Beijing”)	·      A PRC limited liability company ·      Incorporated on June 14, 2016 ·      Subscribed capital of $1,454,038 (RMB 10,000,000) ·      Stem cell storage and bank	VIE of Yubo Chengdu WFOE
Yubo Jingzhi Biotechnology (ChengDu) Co. Ltd. (“Yubo Jingzhi”)	·          A PRC company incorporated on January 21, 2021	73% owned by Yubo Beijing
Yubo Global Biotechnology (Chengdu) Co. Ltd (“Yubo Global”)	·          A PRC company incorporated on December 20, 2020	100% owned by Platinum HK
Phoenix Club Bio-Medical Technology (Chengdu) Co., LTD (“Yubo Phoenix”)	·          A PRC company incorporated on April 12, 2021	100% owned by Yubo Beijing
EpiAis Biomedical Engineering Co., Ltd. (“Yubo Shenzhen”)	·          A PRC company incorporated on January 26, 2024	51% owned by Yubo Beijing

Schedule of assets and liabilities of Yubo Beijing (VIE)

	March 31, 2024			December 31, 2023
	(Unaudited)
Cash	$	707		$	1,115
Receivables (net)		27,705			28,249
Prepaid Expenses		33,756			107,921
Inventory		209,536			214,575
Due from related parties		280,468			285,974
Property and equipment (net)		28,144			13,806
Intangible assets (net)		61,242			54,409
Operating lease right of use asset		105,108			182,856
Lease security deposit		81,599			83,201
Investment in Yubo Jingzhi and Yubo Phoenix (A)		254,883			259,887
Receivables from other consolidated entities (A)		377,095			357,860
Total assets		1,460,243			1,589,853
Accounts payable and accrued expenses		458,796			454,411
Advances from prospective customers/distributors		425,792			434,151
Due to related parties		1,887,254			1,690,922
Operating lease liabilities		105,108			182,856
Payables to other consolidated entities (A)		426,271			459,181
Total liabilities		3,303,221			3,221,521
Shareholders' equity	$	(1,842,978	)	$	(1,631,668	)

Schedule of Property and Equipment

Leasehold improvements	Remaining term of lease
Air conditioning equipment	5 years
Office equipment	3 years

Schedule of amortization period of intangible assets

Distribution software	5 years
Patents	20 years